Probiotic Bifidobacterium animalis subsp. Lactis Bi-07 alleviates bacterial translocation and ameliorates microinflammation in experimental uraemia

Nephrology

Volumn 19, Issue 8, 2014, Pages 500-506

  Wei, Meng ^a   Wang, Zhigang ^a   Liu, Hua ^a   Jiang, Hongli ^a   Wang, Meng ^a   Liang, Shanshan ^a   Shi, Kehui ^a   Feng, Jie ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

bacterial translocation; intestinal permeability; microinflammation; probiotic; uraemia

Indexed keywords

CREATININE; ENDOTOXIN; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 6; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UREA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM ANIMALIS BI 07; COLON; COLON MUCOSA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ESCHERICHIA COLI; HEMATOCRIT; HISTOLOGY; ILEUM; INFLAMMATION; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; JEJUNUM; LAPAROTOMY; LIVER; MALE; MESENTERY LYMPH NODE; MICROINFLAMMATION; NEPHRECTOMY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SPLEEN; UREMIA; URINE VOLUME; ANIMAL; BIFIDOBACTERIUM; COMPLICATION; DRUG EFFECTS; INTESTINE; MICROBIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM; INFLAMMATION; INTESTINES; MALE; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY; UREMIA;

EID: 84904915345     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12272     Document Type: Article

References (33)

1. Guarner C, Runyon BA, Young S, Heck M, Sheikh MY,. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J. Hepatol. 1997; 26: 1372-1378.
2. Cicalese L, Sahai A, Sileri P, et al. Acute pancreatitis and bacterial translocation. Dig. Dis. Sci. 2001; 46: 1127-1132.
3. Jones WG, 2nd, Minei JP, Barber AE, et al. Bacterial translocation and intestinal atrophy after thermal injury and burn wound sepsis. Ann. Surg. 1990; 211: 399-405.
4. Sandek A, Bauditz J, Swidsinski A, et al. Altered intestinal function in patients with chronic heart failure. J. Am. Coll. Cardiol. 2007; 50: 1561-1569.
5. Amar J, Chabo C, Waget A, et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: Molecular mechanisms and probiotic treatment. EMBO Mol. Med. 2011; 3: 559-572.
6. Vaziri ND,. CKD impairs barrier function and alters microbial flora of the intestine: A major link to inflammation and uremictoxicity. Curr. Opin. Nephrol. Hypertens. 2012; 21: 587-592.
7. Kotanko P, Carter M, Levin NW,. Intestinal bacterial microflora-a potential source of chronic inflammation in patients with chronic kidney disease. Nephrol. Dial. Transplant. 2006; 21: 2057-2060.
8. Koninkx JFJG, Tooten PCJ, Malago JJ,. Probiotic bacteria induced improvement of the mucosal integrity of enterocyto-like caco-2 cells after exposure to salmonella enteritidis 857. J. Func. Foods 2010; 2: 225-234.
9. Mogilner JG, Srugo I, Lurie M, et al. Effect of probiotics on intestinal regrowth and bacterial translocation after massive small bowel resection in a rat. J. Pediatr. Surg. 2007; 42: 1365-1371.
10. Wang B, Huang Q, Zhang W, Li N, Li J,. Lactobacillus plantarum prevents bacterial translocation in rats following ischemia and reperfusion injury. Dig. Dis. Sci. 2011; 56: 3187-3194.
11. Wang F, Zhang P, Jiang H, Cheng S,. Gut bacterial translocation contributes to microinflammation in experimental uremia. Dig. Dis. Sci. 2012; 57: 2856-2862.
12. Boyle RJ, Robins-Browne RM, Tang MLK,. Probiotic use in clinical practice: What are the risks? Am. J. Clin. Nutr. 2006; 83: 1256-1264.
13. Briczinski EP, Loquasto JR, Barrangou R, Dudley EG, Roberts AM, Roberts RF,. Strain-specific genotyping of Bifidobacterium animalis subsp. lactis by using single-nucleotide polymorphisms, insertions, and deletions. Appl. Environ. Microbiol. 2009; 75 (23): 7501-7508.
14. Sambrook J, Fritsch E, Maniatis T,. Molecular Cloning: A Laboratory Manual, 2nd edn. New York: Cold Spring Harbor Laboratory Press, 1989.
15. Requena T, Burton J, Matsuki T, et al. Identification, detection, and enumeration of human bifidobacterium species by PCR targeting the transaldolasegene. Appl. Environ. Microbiol. 2002; 68: 2420-2427.
16. Zareie M, De Vriese AS, Hekking LH, et al. Immunopathological changes in a uraemic rat model for peritoneal dialysis. Nephrol. Dial. Transplant. 2005; 20: 1350-1361.
17. de Almeida Duarte JB, de Aguilar-Nascimento JE, Nascimento M, Nochi RJ Jr,. Bacterial translocation in experimental uremia. Urol. Res. 2004; 32: 266-270.
18. Wang FQ, Jiang HL, Shi KH, et al. Gut bacterial translocation is associated with microinflammation in end stage renal disease patients. Nephrology 2012; 17: 733-738.
19. Chacaltana A, Velarde H, Espinoza J,. Endoscopic lesions in the upper digestive tract in patients with terminal chronic renal insufficiency. Rev. Gastroenterol. Peru 2007; 27: 246-252.
20. Vaziri ND, Yuan J, Nazertehrani S, Ni Z, Liu S,. Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction. Am. J. Nephrol. 2013; 38: 99-103.
21. Vaziri ND, Yuan J, Rahimi A, Ni Z, Said H, Subramanian VS,. Disintegration of colonic epithelial tight junction in uremia: A likely cause of CKD-associated inflammation. Nephrol. Dial. Transplant. 2012; 27: 2686-2693.
22. Vaziri ND, Wong J, Pahl M, et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 2013; 83: 308-315.
23. Wong J, Piceno YM, DeSantis TZ, Pahl M, Andersen GL, Vaziri ND,. Expansion of urease and uricase-containing, indole- and p-cresol-forming and contraction of short chain fatty acid-producing intestinal bacteria in ESRD. Am. J. Nephrol. 2014; 39: 230-237.
24. Vaziri ND, Yuan J, Norris K,. Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in CKD. Am. J. Nephrol. 2012; 37: 1-6.
25. Anders HJ, Andersen K, Stecher B,. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int. 2013; 83: 1010-1016.
26. McIntyre CW, Harrison LE, Eldehni MT, et al. Circulating endotoxemia: A novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2011; 6: 133-141.
27. Bossola M, Sanguinetti M, Scribano D, et al. Circulating bacterial-derived DNA fragments and markers of inflammation in chronic hemodialysis patients. Clin. J. Am. Soc. Nephrol. 2009; 4: 379-385.
28. Savard P, Lamarche B, Paradis ME, Thiboutot H, Laurin É, Roy D,. Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults. Int. J. Food Microbiol. 2011; 149: 50-57.
29. Agostini S, Goubern M, Tondereau V, et al. A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats. Neurogastroenterol. Motil. 2012; 24: 376-e172.
30. Klein A, Friedrich U, Vogelsang H, Jahreis G,. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults. Eur. J. Clin. Nutr. 2008; 62: 584-593.
31. Lee HB, Blaufox MD,. Blood volume in the rat. J. Nucl. Med. 1985; 25: 72-76.
32. Young RJ, Vanderhoof JA,. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J. Pediatr. Gastroenterol. Nutr. 2004; 39: 436-437.
33. Pérez-Conesa D, Lõpez G, Ros G,. Effect of probiotic prebiotic and synbiotic follow-up infant formulas on large intestine morphology and bone minerlisation in rats. J. Sci. Food Agric. 2007; 6: 1059-1068.